Chase, Erin
Mena, Leandro
Johnson, Kendra L.
Prather, Mariah
Khosropour, Christine M. http://orcid.org/0000-0002-9743-0829
Funding for this research was provided by:
National Institute of Mental Health (R21MH125608)
Health Resources and Services Administration (U66RH31459)
Center for AIDS Research, University of Washington (AI027757)
Article History
Accepted: 27 August 2022
First Online: 12 September 2022
Declarations
:
: L.M. has received grants from: Gilead Sciences, GSK/ViiV Healthcare, Merck, Roche Molecular, Visby Medical, Binx Health. Evofem Inc, click Dx, Janssen Pharmaceutical, Prosoft Clinical, ThaiMed, SpeedDx Pty LTD., and consulting or advisory fees: from Gilead Sciences, GSK/ViiV Healthcare, Merck, Roche Molecular. C.M.K. has received donations of specimen collection kits and reagents for studies outside the submitted work. All other authors declare no conflicts of interest.
: This analysis was undertaken as a program evaluation of this HRSA-funded program, with the intent for the results to be used to improve the program’s operations. Thus, it was exempt from human subjects research approval.
Free to read: This content has been made available to all.